UB Paderborn / Katalog / Suche / in CDI

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor

Journal of clinical medicine, 2020-10, Vol.9 (11), p.3402

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project

Health and quality of life outcomes, 2012-07, Vol.10 (1), p.82-82

2012

Link zum Volltext

Verfügbarkeit prüfen

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Global & regional health technology assessment (Online), 2022-01, Vol.9 (1), p.14-21

2022

Link zum Volltext

Verfügbarkeit prüfen

Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-04, Vol.10 (4), p.1020-1028

2022

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE‐PLG patients

Allergy (Copenhagen), 2020-08, Vol.75 (8), p.2099-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Hereditary angioedema with F12 mutation

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.520-526

2016

Link zum Volltext

Verfügbarkeit prüfen

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Allergy, 2014-05, Vol.69 (5), p.602-616

2014

Link zum Volltext

Verfügbarkeit prüfen

Hereditary angioedema with F12 mutation: Clinical features and enzyme polymorphisms in 9 Southwestern Spanish families

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.520-526

2016

Link zum Volltext

Verfügbarkeit prüfen

Mutational spectrum of the SERPING1 gene in a pediatric population from Southern Spain with Hereditary Angioedema due to C1 inhibitor deficiency

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB45-AB45

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency

Journal of investigational allergology & clinical immunology, 2016-01, Vol.26 (3), p.161-167

2016

Link zum Volltext

Verfügbarkeit prüfen

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

The New England journal of medicine, 2018-07, Vol.379 (4), p.352-362

2018

Link zum Volltext

Verfügbarkeit prüfen

CA 125: Marker of serosal inflammation in hereditary angioedema?

Allergy (Copenhagen), 2005-06, Vol.60 (6), p.835-836

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

Journal of clinical immunology, 2011-10, Vol.31 (5), p.752-761, Article 752

2011

Link zum Volltext

Verfügbarkeit prüfen

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

Allergy, 2017-02, Vol.72 (2), p.300-313

2017

Link zum Volltext

Verfügbarkeit prüfen

Anaphylaxis to Omeprazole

The World Allergy Organization journal, 2007-11, p.S269

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Hizentra super( registered ), a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

Journal of clinical immunology, 2011-10, Vol.31 (5), p.752-761

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Hizentra^sup ®^, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

Journal of clinical immunology, 2011-10, Vol.31 (5), p.752

2011

Link zum Volltext

Verfügbarkeit prüfen

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

Molecular immunology, 2008-10, Vol.45 (16), p.4118-4119

2008

Link zum Volltext

Verfügbarkeit prüfen

International Consensus on the Use of Genetics in the Management of Hereditary Angioedema

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-03, Vol.8 (3), p.901-911

2020

Link zum Volltext

Verfügbarkeit prüfen

Solution structure of the complex between human complement C3d and full length complement receptor type 2

Molecular immunology, 2008-10, Vol.45 (16), p.4120-4120

2008

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life of Patients with Primary Immunodeficiency Switching from Intravenous IgG to a New 20% Subcutaneous IgG

Clinical immunology (Orlando, Fla.), 2010, Vol.135, p.S87-S87

2010

Link zum Volltext

Verfügbarkeit prüfen

Alpha-1 antitrypsin deficiency hidden in allegedly normal variants

The Journal of asthma, 2022-07, Vol.59 (7), p.1372-1375

2022

Link zum Volltext

Verfügbarkeit prüfen

Classification of angioedema without wheals

Annals of allergy, asthma, & immunology, 2016-02, Vol.116 (2), p.177-177

2016

Link zum Volltext

Verfügbarkeit prüfen

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations

Journal of investigational allergology & clinical immunology, 2011, Vol.21 (6), p.422-41; quiz 442-3

2011

Link zum Volltext

Verfügbarkeit prüfen

Tratamiento de las quemaduras de espesor parcial con quitina en polvo

Revista cubana de medicina militar, 1996-12, Vol.25 (1)

1996

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor

Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Angioedema Due to Acquired Deficiency of C1-Inhibitor: A Cohort Study in Spain and a Comparison With Other Series

Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE‐PLG patients

Hereditary angioedema with F12 mutation

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Hereditary angioedema with F12 mutation: Clinical features and enzyme polymorphisms in 9 Southwestern Spanish families

Mutational spectrum of the SERPING1 gene in a pediatric population from Southern Spain with Hereditary Angioedema due to C1 inhibitor deficiency

Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

CA 125: Marker of serosal inflammation in hereditary angioedema?

Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

Anaphylaxis to Omeprazole

Efficacy and Safety of Hizentra super( registered ), a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

Efficacy and Safety of Hizentra^sup ®^, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

International Consensus on the Use of Genetics in the Management of Hereditary Angioedema

Solution structure of the complex between human complement C3d and full length complement receptor type 2

Health-Related Quality of Life of Patients with Primary Immunodeficiency Switching from Intravenous IgG to a New 20% Subcutaneous IgG

Alpha-1 antitrypsin deficiency hidden in allegedly normal variants

Classification of angioedema without wheals

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations

Tratamiento de las quemaduras de espesor parcial con quitina en polvo

Suchergebnisse filtern